| 标题 |
 A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Global Oncology 作者：Howard A. Burris III; Manish R. Patel; Daniel C. Cho; Jeffrey Melson Clarke; Martin Gutierrez; et al 出版日期：2019-10-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
GingerF
kaio_escolar
OK
秦艽
忧心的曼凝
无极微光
mmmm
My_magnum_opus
老迟到的涫
cc
ohhh
DW
包容如雪
YYANG
年年有余
mmyhn
学霸业
Elsevier大王
0_O
皖公网安备34019202002308
